# | Title | Journal | Year | Citations |
---|
1 | 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk | Atherosclerosis | 2019 | 1,753 |
2 | Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? | Atherosclerosis | 2000 | 1,611 |
3 | 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias | Atherosclerosis | 2016 | 1,189 |
4 | Divergent associations of tissue inhibitors of metalloproteinases-1 and -2 with the prothrombotic/fibrinolytic state | Atherosclerosis | 2007 | 1,107 |
5 | Adhesion molecules and atherosclerosis | Atherosclerosis | 2003 | 924 |
6 | Conjugated linoleic acid and atherosclerosis in rabbits | Atherosclerosis | 1994 | 918 |
7 | Quantitative assessment of atherosclerotic lesions in mice | Atherosclerosis | 1987 | 894 |
8 | Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines | Atherosclerosis | 1999 | 862 |
9 | Oxysterols and atherosclerosis | Atherosclerosis | 1999 | 824 |
10 | Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998 | Atherosclerosis | 1998 | 760 |
11 | Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase | Atherosclerosis | 1993 | 737 |
12 | High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study | Atherosclerosis | 2004 | 695 |
13 | Lipoprotein Lp(a) and the risk for myocardial infarction | Atherosclerosis | 1981 | 687 |
14 | The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levels | Atherosclerosis | 1986 | 640 |
15 | High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport | Atherosclerosis | 1996 | 638 |
16 | Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review | Atherosclerosis | 2006 | 629 |
17 | Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: A meta-analysis | Atherosclerosis | 2012 | 601 |
18 | The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation | Atherosclerosis | 2015 | 587 |
19 | Influences of age and gender on results of noninvasive brachial–ankle pulse wave velocity measurement—a survey of 12 517 subjects | Atherosclerosis | 2003 | 572 |
20 | Variation in susceptibility to atherosclerosis among inbred strains of mice | Atherosclerosis | 1985 | 561 |
21 | ESC/EAS Guidelines for the management of dyslipidaemias | Atherosclerosis | 2011 | 561 |
22 | Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit) *1Incidence and development of atherosclerosis and xanthoma | Atherosclerosis | 1980 | 553 |
23 | New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study | Atherosclerosis | 1997 | 541 |
24 | Vascular oxidative stress, nitric oxide and atherosclerosis | Atherosclerosis | 2014 | 519 |
25 | Endothelin is a potent mitogen for rat vascular smooth muscle cells | Atherosclerosis | 1989 | 515 |
26 | Atherosclerotic plaque caps are locally weakened when macrophages density is increased | Atherosclerosis | 1991 | 513 |
27 | HDL and arteriosclerosis: beyond reverse cholesterol transport | Atherosclerosis | 2002 | 511 |
28 | Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk | Atherosclerosis | 1994 | 506 |
29 | Non-alcoholic fatty liver disease and increased risk of cardiovascular disease | Atherosclerosis | 2007 | 500 |
30 | Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study | Atherosclerosis | 1994 | 494 |
31 | LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture | Atherosclerosis | 1979 | 493 |
32 | A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia | Atherosclerosis | 2003 | 490 |
33 | Distribution of macrophage polarization markers in human atherosclerosis | Atherosclerosis | 2012 | 490 |
34 | Influence of age and menopause on serum lipids and lipoproteins in healthy women | Atherosclerosis | 1993 | 482 |
35 | Postprandial lipoproteins and progression of coronary atherosclerosis | Atherosclerosis | 1994 | 472 |
36 | Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives | Atherosclerosis | 2008 | 470 |
37 | The ratio of ankle and arm arterial pressure as an independent predictor of mortality | Atherosclerosis | 1991 | 465 |
38 | Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size | Atherosclerosis | 1992 | 461 |
39 | Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus | Atherosclerosis | 1991 | 458 |
40 | Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease | Atherosclerosis | 1997 | 451 |
41 | Chemokines and atherosclerosis | Atherosclerosis | 1999 | 451 |
42 | Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study | Atherosclerosis | 1990 | 437 |
43 | Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects | Atherosclerosis | 1988 | 425 |
44 | Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia | Atherosclerosis | 2004 | 425 |
45 | Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: | Atherosclerosis | 1997 | 424 |
46 | Leptin and atherosclerosis | Atherosclerosis | 2006 | 421 |
47 | Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? | Atherosclerosis | 2000 | 420 |
48 | Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease | Atherosclerosis | 2014 | 419 |
49 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice | Atherosclerosis | 2016 | 415 |
50 | The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study | Atherosclerosis | 2004 | 414 |